liver function test and clinical aspect sctl (1)

Upload: shalini-soorya

Post on 08-Apr-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    1/54

    LIVER FUNCTION TEST ANDCLINICAL ASPECT

    DR Nani Nordin

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    2/54

    Learning Objective

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    3/54

    Activity 1

    Outline major functions of the liver.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    4/54

    Functions of Liver Metabolic:Glucose metabolismStored as glycogen.

    Glycogenolysis and gluconeogenesis during fasting.LipidFormation of VLDL to transport endogenous TGto adipose tissue.

    Convert fatty acid from adipose tissue to ketone duringfasting.Storage of vitamin D, vitamin B12 and iron.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    5/54

    Functions of the liver

    Synthetic Functions Plasma protein all except Ig and complement.

    Coagulation factors. Lipoprotein VLDL and HDL Primary bile acids

    Deficiencies in synthetic functions occur inextensive liver dz due to large functionalreserve.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    6/54

    Functions of the liver

    Excretion and DetoxificationBilirubin excretion.

    Amino acids.Cholesterol.Steroid hormones.Drugs-metabolized and inactivated by

    enzyme of endoplasmic reticulum.Toxins- via kupffer cells.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    7/54

    Activity 2

    Describe bilirubin metabolism in adiagram.

    Explain the difference between conjugatedand uncojugated bilirubin. What is urobilinogen?

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    8/54

    Bilirubin

    Indirect bilirubin formed in themacrophages of thespleen and marrow.

    Water insoluble Toxic- because cancross BBB

    Direct bilirubin Formed in the liver:conjugated with

    glucuronic acid by theenzyme UDP-glucuronyltransferase

    Water soluble

    U nconjugated

    Together these two forms comprise the total bilirubin in the serum.

    conjugated + unconjugated = total bilirubin

    Conjugated

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    9/54

    Bilirubin Metabolism Erythrocytes are destroyed by

    macrophages in the spleen and bonemarrow, releasing hemoglobin heme

    The globin portion is metabolizedamino acids.

    The heme is converted intounconjugated bilirubin in macrophages

    of the spleen and bone marrow, boundto plasma albumin and transported tothe liver.

    There it is conjugated with glucuronicacid by the enzyme UDP-glucoronyltransferase , making it water soluble for excretion in the bile.

    The conjugated bilirubin in the bile isdelivered into the small intestine andexcreted as urobilinogen.

    HAEM

    BILIVERDIN

    BILIRUBIN IX

    Fe 2+

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    10/54

    Urobilinogen

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    11/54

    Activity 3

    Define jaundice. Explain the pathophysiology of jaundice.

    List the causes of jaundice.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    12/54

    J aundice

    Yellow staining of the skin and sclerae byabnormally high level of bilirubin pigment.

    J aundice is clinically apparent whenbilirubin reaches about 35 mol/L.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    13/54

    Pathophysiology of J aundice Occurs when bilirubin production exceed liver capacity to excrete.

    Pre-hepatic-Increase rate of bilirubin productionexceeds the hepatic artery to excrete it.

    Hepatic- When the normal load of bilirubincannot be conjugated and/or excreted bydamaged liver cells.

    Post hepatic- Biliary flow is obstructedconjugated bilirubin cannot be excreted into theintestine and regurgitated into the systemiccirculation.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    14/54

    Causes of J aundice

    Prehepatic Haemolysis, ABO incompatiblity

    Hepatic Congenital -Gilberts Syndrome, Crigler-Najjar Hepatic infiltration- Hepatitis(viral, autoimmune,alc,drugs) ,CirrhosisMetabolic - Haemochronatosis ,Wilsons dz ,A-1-antitrypsin deficiencyLiver malignancy- Primary ,Secondary

    Post-hepatic Biliary obstructionGall stonePancreatic tumor Primary biliary cirrhosisSclerosing Cholangitis

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    15/54

    Activity 4

    What are the roles of liver function test? Lists the parameters measured in a liver

    function test. Discuss the significance of derangementof these parameters.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    16/54

    THE ROLE OF LIVER FUNCTION

    TESTTests of liver function are used for:

    1. Screening for abnormalities in liver function

    2. Documenting an abnormality3. Identifying the type and site of injury4. Prognostication and follow-up of patients

    with hepatic disease

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    17/54

    COMPONENT OF LFT Bilirubin- conjugated and unconjugated Total protein and albumin Liver enzymes

    Alanine transaminase (ALT)Aspartate transaminase (AST)Alkaline phosphatase (ALP)Gamma glutamyltransferase (GGT)

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    18/54

    Bilirubin Serum Total bilirubin = direct (conjugated) +indirect (unconjugated) bilirubin

    Urinary bilirubin : normally there is no bilirubin in the urine, because

    unconjugated bilirubin exists in the plasma attachedto albumin.

    Bilirubin in urine means that there is o level of conjugated bilirubin e.g. in obstructive jaundice andhepatitis

    Usually estimated by a dipstick method.

    Urinary urobilinogen : o in hemolysis or if there is interference to hepaticexcretion of urobilinogen ( from enterohepatic circ .)

    Its absence from urine indicate that there is completeobstruction to hepatic bilirubin excretion.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    19/54

    PLASMA TOTAL PROTEINS ANDALBUMIN

    The total proteins estimates both albuminand globulins

    Albumin is wholly synthesized in the liver and low levels suggest severe hepatocytedysfunction

    The globulin fraction, which includes the

    immunoglobulins, are usually increased inchronic liver disease (e.g. chronichepatitis)

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    20/54

    PLASMA TRANSAMINASES

    Aspartate aminotransferase (AST) andalanine aminotransferase (ALT) arepresent in large quantities in thehepatocyte.

    Diseases which cause hepatocytedestruction (e.g. hepatitis) results in therelease of these enzymes.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    21/54

    PLASMA ALKALINEPHOSPHATASE (ALP)

    Found in the cells lining the bile passagesand on the secretory side of thehepatocyte membrane walls

    o plasma levels are found in obstructivejaundice.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    22/54

    PLASMA GGT

    Located on the hepatocyte membrane andis increased in cholestasis

    Its activity is also increased (enzymeinduction) by a number of drugs andtoxins (e.g. alcohol, phenytoin sodium)

    Thus, high plasma GGT levels do notalways indicate liver disease.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    23/54

    Activity 5

    Define acute liver injury and chronic liver injury.

    Lists the causes acute and chronic liver injury. Discuss the biochemical findings in acuteand chronic hepatitis

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    24/54

    Acute Liver Injury

    Acute hepatic injury refers to hepatocytedamage that occurs abruptly and over ashort period of time.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    25/54

    Chronic Liver Injury Chronic hepatic injury refers to continuing hepatocyte damage for

    more than 6 months. It is defined pathologically by ongoing hepatic necrosis and

    inflammation in the liver, often accompanied by fibrosis. Chronic hepatocyte injury is usually recognized by slight elevation of

    aminotransferases (usually less than 4 times the upper referencelimit), although activities may be intermittently elevated and, in asmall percentage of cases, persistently within reference limits.

    Persistence of increased ALT for more than 6 months after an episodeof acute hepatitis OR

    Elevation of ALT (without another explanation) on more than oneoccasion over a period of 6 months. A shorter time may beappropriate in patients with risk factors for chronic viral hepatitis,genetic causes of hepatic injury, or autoimmune liver injury; or in thepresence of clinical signs or symptoms of liver disease. (IIB).

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    26/54

    Causes of acute liver injury

    Hepatitis-viral (hepatitis virus, CMV, EBV,alcohol

    Toxic injury Ischaemic injury Wilsons disease

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    27/54

    Causes of chronic liver injury Hepatitis virus

    Non-alcoholic steatohepatitis

    Hemochromatosis

    Wilsons Disease

    Autoimmune hepatitis

    Primary biliary cirrhosis

    Sclerosing cholangitis

    Alpha-1-antitrypsin deficiency

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    28/54

    Acute hepatitis Chronic hepatitis

    Definition Acute inflammation of the liver.May be caused by viral , drugs,toxic agents

    Chronic inflammatoryreaction of the liver of morethan 6 months

    Clinical presentation andphysical findings

    Hx of anorexia, nauseatenderness or discomfort over the liver Fever, + jaundice, enlargedtender liver

    Lab. findings Biochemical findings arepredominantly those of cellmembrane damage: ALT>ASTPlasma transaminases are veryhigh at the onset of symptomsThere may be superimposed

    cholestatic picture~jaundice,pale stools and dark urineComplete lab recovery:

    Hepatitis A: 9 weeksHepatitis B: 16weeks may becomechronic

    Persistently abnormalserum transaminases

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    29/54

    Activity 6Liver pathology can be classified according

    to theLFTs results as:

    Hepatocellular

    Cholestatic (obstructive) Mixed hepatocellular and cholestatic

    Give examples of diseases in therespective category

    Explain the expected LFT derangement inhepatocellular and cholestatic liver injury.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    30/54

    Category Hemolytic/Iron overload

    Hepatocellular O bstructive

    ALT Normal o Normal or o

    AST Normal o Normal or oALP/GGT Normal o or Normal o o o

    CONJU GATEDBILIRU BIN

    Normal o o

    UN CONJU GATEDBILIRU BIN

    o o Normal

    URO BILINO GE N IN THE UR IN E

    o o or Normal q

    R epresentativediseases

    Haemolytic anemias,thalassemia major

    Multiple transfusion

    Acute hepatitis,cirrhosis,

    Drug toxicityReye syndrome

    Obstruction:intrahepatic,

    extrahepaticSpace-occupying

    lesionsDrugs

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    31/54

    Hepatocellular destruction

    Damage to cells release of intracellular enzymes o plasma levels of AST & ALT(up to 10x). (Normal ALT

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    32/54

    Cholestasis Defines as obstruction to bile outflow occurring

    anywhere between the secretory surface of thehepatocyte and the junction of the bile ducts with theduodenum.

    The characteristic features are jaundice and a highplasma ALP level, usually greater than 3x normal

    The plasma bilirubin is mainly conjugated (backflow). Plasma ALT may be normal or mildly o

    If obstruction persist hepatocellular destruction may besignificant and very high plasma levels of ALTs will occur Plasma GGT is always o .

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    33/54

    Obstructive jaundice

    IntrahepaticIntrahepatic : hepatitis, tumour, cholangitis,drugs

    Extrahepatic jaundiceExtrahepatic jaundice : cholelithiasis,tumor, biliary stricture, biliary atresia

    SpaceSpace- -occupying lesionoccupying lesion : tumor, cysts,granuloma, abscess

    DrugsDrugs CirrhosisCirrhosis : alcoholic, biliary, cryptogenic,Wilsons disease, haemachromatosis.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    34/54

    It is important to distinguish hepatocellular jaundice fromextrahepatic obstructive jaundice, because the latter isan indication for exploratory surgery. The biochemicalfindings are similar but one useful laboratory test is the

    measurement of alkaline phosphatase (ALP).alkaline phosphatase (ALP). ALP may come from the liver, bone, intestine and

    placenta. Serum ALP may be 3xo in obstructive jaundice, while

    90% of patients with hepatocellular jaundice have valuesless than that.

    Patients with hepatocellular jaundice also tend to havemarked elevation of serum LD, ALT, AST and GGT

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    35/54

    Activity 7

    List common drugs that can cause liver disease.

    Briefly explain the mechanism of liver damage by acetaminophen.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    36/54

    Activity 8

    3 metabolic conditions that can cause liver injury include: Wilsons disease

    Haemochromatosis1-antitrypsin deficiencyheBriefly describe these 3 conditions and

    state relevant laboratory investigationsrequired for the diagnosis.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    37/54

    Metabolic liver diseaseDisease Presentation Diagnosis and Laboratory findings

    EE 11--antitrypsinantitrypsindeficiencydeficiency

    Pulmonary emphysema inchildhoodHepatitis in neonatesCirrhosis in children andyoung adults

    Dz is confirmed demostrating a lowplasma E 1-antitrypsin and byidentifying the phenotype

    WilsonsWilsons

    Disease:Disease:RecessivelyinheritedCaused byimpaired hepaticincorporation of

    copper intocaeruloplasmin

    Present at 10-30 years due

    to excessive deposition of copper in the liver and brain

    Acute hepatitis or Parkinson-likeextrapyrimidal symptoms.

    Kayser-fleischer ring isfound

    Low plasma copper and

    ceruloplasminIncreased urinary copper excretionLiver biopsy: increased copper

    content

    HemochromatosisHemochromatosis: Recessivelyinherited

    Onset usually after age 50Arthropathy, cardiomegaly,

    hepoatomegaly, skinpigmentation,

    Mild abnormal LFTsElevated plasma iron>50% saturation of the transferrin

    Liver biopsy: excess iron in the liver

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    38/54

    Case 1

    A 24-year-old known intravenous drug user presented with jaundice and RHC pain

    since 1 week.On the day prior to the development of jaundice he noted that his urine was dark.

    His liver function tests were as follows.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    39/54

    Referenceinterval

    Albumin 35g/L 30-50

    Bilirubin 250mol/L 1-20

    AST 1420 U/L

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    40/54

    What do these results suggest? J ustify Why was her urine dark?

    What further investigations required topredict severity of the liver disease?

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    41/54

    1) What do these results suggest? J ustify.Acute liver injury most likely acute hepatitis.J ustification:From history 1 week indicate acute problem.

    Very high in transaminases (ASTx30, ALTx45)compared to increase in ALP (2-7X)- indicateshepatocellular damage.

    Painful RHC suggests inflammation.Most likely diagnosis is acute hepatitis.Need to further confirmed with hepatitis screening.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    42/54

    2) Why is her urine dark?Dark coloured urine is due to the presence of conjugated bilirubin and

    increase in urobilinogen.Conjugated bilirubin is water soluble and a small molecule, thus it can

    be filtered by the glomeruli.The presence of bilirubin in the urine indicates increase plasma levels

    of conjugated form.95% of bilirubin normally present in the plasma is uncojugated .

    Therefore , a positive urine bilirubin is always pathological and maybe the earliest indication of hepatitis.

    Urinary urobilinogen are raised when increased amounts of bilirubinenters the gut (haemolysis) or ifthere is impaired re-excretion of theurobilinogen arriving via enterohepatic circuation (liver damage).Colourless urobilinogen can be oxidized into a coloured pigment,urobilin.

    Urine urobilinogen often detected in a normal person.The presence of urine urobilinogen is not useful in the diagnosis of iver diseaseunless it present in high amount.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    43/54

    3) What further investigations required topredict severity of the liver disease?

    Prothrombin time (PT)Most important prognostic factor of hepaticinjury.Prolonged PT of > 4 secs above upper

    refrence limit indicates severe liver injury.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    44/54

    Case 2

    A 48-year-old, with a 20 year history of alcoholism was admitted for management of

    alcohol withdrawal. Physical examinationrevealed slightly yellow sclera and anenlarged, hard, non-tender liver. He had been

    well previously and was not on medication.His liver function tests were as follows.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    45/54

    Ref Range

    Total protein 65g/L 60-80

    Albumin 26g/L 30-50ALP 500 U/L 30-120

    ALT 64U/L

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    46/54

    1) What is the possible diagnosis. J ustify.2) Explain elevated GGT.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    47/54

    1) What is the possible diagnosis. J ustify.Low albumin indicates chronic liver

    disease.Mild increase in liver enzymes with predominant increasein ALPx16 ,ALTx2 indicate predominance obstructivelesion/ cholestatic jaundice.

    Ddx -Biliary obstruction

    - Drug reaction- Liver cirrhosisBilirubin level is usually higher in biliary obstruction. In this

    case bilirubin only increase by 2X.Most likely diagnosis is liver cirrhosis due to alcohol

    consumption.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    48/54

    2) Explain elevated GGT.Increase GGT is due to enzyme induction

    eg alcohol .It also indicates damage to the hepatobiliarytract.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    49/54

    Case 3

    A 40 year-old-female complain of epigastricpain radiated to the back associated with

    jaundice. Urine was dark and stool was pale.Her LFT were as followed.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    50/54

    Ref Range

    Total protein 78g/L 60-85

    Albumin 39g/L 30-50ALP 620 U/L 30-120

    ALT 55 U/L

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    51/54

    1) What is the possible diagnosis? J ustify2) What further investigation required?

    3) Explain the pale stool.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    52/54

    1) What is the possible diagnosis? J ustifySignificant increase in ALP (X20) and

    GGT suggest cholestatic liver injury.This result in a very high bilirubin level.

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    53/54

    2) What further investigation required?Ultrasound of biliary tract and gall bladder

    to look for presents of stone, dilated ducts,thickness of GB wall.ERCP

  • 8/7/2019 LIVER FUNCTION TEST AND CLINICAL ASPECT sctl (1)

    54/54

    3) Explain the pale stool.Brown pigment in the stool is due the

    presence of stercobilin.Stercobilin is formed by the oxidation of

    urobilinogen in the colon by the gut flora.In biliary obstruction, lack of conjugated

    bilirubin excreted to the gut to beconverted to urobilinogen, hence palestool.